From: Clinical significance of D-dimer levels during acute period in ischemic stroke
 | Initial D-dimer level (mg/L)* | Follow-up D-dimer level (mg/L)* | ||
---|---|---|---|---|
 | β (95% CI) | P value | β (95% CI) | P value |
Initial NIHSS score [IQR] | 0.036 (0.020 to 0.052) | < 0.001 | 0.032 (0.015 to 0.049) | < 0.001 |
Early neurological deterioration, (%) | 0.470 (0.197 to 0.743) | 0.001 | 0.604 (0.321 to 0.888) | < 0.001 |
Stroke mechanism, (%) | Â | Â | Â | Â |
Large artery atherosclerosis | -0.214 (-0.473 to 0.044) | 0.104 | -0.308 (-0.578 to -0.038) | 0.026 |
Small-vessel occlusion | -0.408 (-0.729 to -0.087) | 0.013 | -0.274 (-0.613 to 0.065) | 0.113 |
Cardioembolism | 0.291 (0.025 to 0.558) | 0.032 | 0.131 (-0.151 to 0.413) | 0.361 |
Other determined | 1.344 (0.767 to 1.921) | < 0.001 | 1.434 (0.830 to 2.039) | < 0.001 |
Undetermined | 0.019 (-0.281 to 0.318) | 0.903 | 0.154 (-0.160 to 0.467) | 0.335 |
Cancer, n (%) | 0.584 (0.252 to 0.915) | 0.001 | 0.575 (0.226 to 0.924) | 0.001 |
Active cancer, n (%) | 0.830 (0.418 to 1.242) | < 0.001 | 1.017 (0.590 to 1.443) | < 0.001 |
Venous thromboembolism, n (%)†| 0.759 (0.177 to 1.341) | 0.011 | 1.128 (0.606 to 1.650) | < 0.001 |
Use of anticoagulants, n (%) | 0.291 (-0.006 to 0.588) | 0.055 | 0.014 (-0.300 to 0.328) | 0.931 |